Trademark Attorney / Law Firm
Mr. Martin J. Beran – Trademark Portfolio
Mr. Martin J. Beran specializes in Class 42 (Computer & Scientific) trademark filings before the United States Patent and Trademark Office (USPTO), with 6 of 8 total filings concentrated in this category. The practice also covers Class 5 (Pharmaceuticals) along with 3 other Nice Classification classes. Filing activity spans from 1995 to 2017. Currently, 1 trademark is registered.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Mr. Martin J. Beran's trademark practice covers 3 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademark applications has Mr. Martin J. Beran filed?
Mr. Martin J. Beran has filed 8 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 1 registered, 1 cancelled.
What trademark classes does Mr. Martin J. Beran specialize in?
Mr. Martin J. Beran has filed trademarks across 3 Nice Classification classes. The most common practice areas include Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment). Class 42 covers scientific and technological services; industrial analysis and research services.
How long has Mr. Martin J. Beran been filing trademarks?
Mr. Martin J. Beran's trademark filing history with the USPTO spans from 1995 to 2017, covering 22 years of trademark practice. During this period, Mr. Martin J. Beran has handled 8 trademark applications.
What is Mr. Martin J. Beran's trademark registration success rate?
Mr. Martin J. Beran has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.